TABRECTA Trademark

Trademark Overview


On Friday, March 21, 2014, a trademark application was filed for TABRECTA with the United States Patent and Trademark Office. The USPTO has given the TABRECTA trademark a serial number of 79148570. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, February 7, 2020. This trademark is owned by NOVARTIS AG. The TABRECTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genito-urinary system, for treatment of inflammatory disorders, for use in dermatology, oncology, hematology, tissue and organ transplantation, ophthalmology and gastro-enterological disorders; pharmaceutical products for the treatment of ocular disorders or diseases, for the treatment of bacterial diseases, and for the treatment of diabetes; anti-infective products, antiviral products, antibiotics, anti-fungal products
tabrecta

General Information


Serial Number79148570
Word MarkTABRECTA
Filing DateFriday, March 21, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, February 7, 2020
Registration Number4630489
Registration DateTuesday, November 4, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 19, 2014

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genito-urinary system, for treatment of inflammatory disorders, for use in dermatology, oncology, hematology, tissue and organ transplantation, ophthalmology and gastro-enterological disorders; pharmaceutical products for the treatment of ocular disorders or diseases, for the treatment of bacterial diseases, and for the treatment of diabetes; anti-infective products, antiviral products, antibiotics, anti-fungal products

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, February 7, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Friday, December 8, 2023INTERNATIONAL REGISTRATION RENEWED
Saturday, October 10, 2020NOTIFICATION PROCESSED BY IB
Friday, February 21, 2020NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, February 21, 2020DEATH OF INTERNATIONAL REGISTRATION
Friday, February 13, 2015NOTIFICATION PROCESSED BY IB
Monday, January 26, 2015FINAL DISPOSITION NOTICE SENT TO IB
Monday, January 26, 2015FINAL DISPOSITION PROCESSED
Thursday, December 4, 2014GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, November 4, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, August 19, 2014PUBLISHED FOR OPPOSITION
Wednesday, July 30, 2014NOTICE OF PUBLICATION
Tuesday, July 15, 2014APPLICATION FILING RECEIPT MAILED
Monday, July 14, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 10, 2014ASSIGNED TO EXAMINER
Thursday, July 10, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 7, 2014LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 3, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB